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Abstract:  
The incidence of Type 1 Diabetes (T1D) is increasing worldwide and is diagnosed 
disproportionately in adolescent populations1,2,3. Additionally, studies show that adolescents with 
T1D experience worse glycemic control during this developmental period6,13,15,18. Maintaining 
glycemic control in patients with T1D decreases the risk of developing future diabetic-related 
complications3,6,14. Factors such as race, ethnicity, gender identity, sexual orientation, 
socioeconomic status, and medical comorbidities influence disparities in maintaining glycemic 
control in adolescents6,11,12,13,15, 17. The recognition of these factors on the management of T1D 
through an integrative team approach leads to increased glycemic control and decreased diabetic-
related complications6,15,19,20,21. This paper explores the effects of psychosocial factors and 
addresses recommendations for effective interventions through multidisciplinary care. The 
literature reviewed in this paper indicates that improving healthcare access, implementing 
behavioral interventions, and increasing the use of diabetic technologies in adolescent 
populations have improved glycemic control and decrease disparities in healthcare outcomes. A 
multidisciplinary team increases patient education and aids in managing and screening for 
comorbidities. Team-based management of T1D also provides behavioral specialists that can 
implement strategies that improve self-management skills and familial involvement15, 21,30,35,43. 
Modern diabetic technology has given patients the tools to increase their healthcare access. It has 
been shown to improve their self-management skills and has allowed providers to individualize 
treatment plans further using data analytic software48,49,50. Improving glycemic control in 
adolescence relies on physical and emotional support from healthcare providers and caregivers.      
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Introduction: 
The incidence of Type 1 Diabetes Mellitus (T1D) has been increasing at a rate of 3-4% 
globally since the 1950s 1. This increase is of particular concern to individuals younger than 18 
years of age as this population has seen the highest increase in incidence, and the majority of 
diagnoses made are between 10-14 years of age1. The U.S. has one of the highest incidences of 
T1D worldwide and is one of the most common endocrine disorders in children and adolescents, 
currently affecting 200,000 people under the age of 205. T1D impacts those diagnosed and their 
caregivers financially, physically, and emotionally2,6. In order to maintain a physiologically 
normal blood glucose level, patients make an additional 180 decisions per day by evaluating 
glycemic levels using self-monitored blood glucose checks (SMBG) and adjusting insulin doses 
based on food intake and activity level1,6. To assess glycemic control in a patient, providers 
monitor hemoglobin A1c values (HbA1c), which indicate the average blood glucose levels 
throughout three months6. To avoid future diabetic-related complications, the American Diabetes 
Association recommends that HbA1c goals be between 7.0-7.5% for patients with T1D between 
13-19 years old6.  
The ability to maintain adequate glycemic control within the individualized parameters 
determined by the healthcare provider is well-established as the chief influence in preventing 
complications related to T1D2,3. Complications of T1D are typically microvascular and 
macrovascular complications requiring rigorous lifelong management and countless medical 
supplies. Patients with T1D are immunocompromised and at higher risk for additional 
autoimmune disorders and mental health disorders, which can compromise glycemic control and 
add to the difficulty of treatment management11,12,13,28. Overall, patients with diabetes have a 
younger age for mortality than the general population14. According to a retrospective cohort 
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study from 2015, the mortality rate for patients with T1D in the U.S. is 5-7 times higher than the 
mortality rate in other developed countries14. Adolescent patients with T1D are of particular 
concern because studies have shown that glycemic control is likely to deteriorate during this 
developmental period and can contribute to further complications in the future3,13,14,16,17. Older 
adult populations are typically diagnosed with T1D-related complications. This pattern is 
attributed to the direct relationship between the duration of the disease and the development of 
diabetic-related pathologies, suggesting that avoiding complications of T1D relies on the 
implementation of prevention strategies in younger age groups7. In addition to the increase in the 
prevalence of T1D in adolescent populations, studies show that patients in this age group 
experience a decline in glycemic control,      -risk 
     T1D5,6,15,18. Therefore, improving care in this population 
may reduce future morbidity and mortality rates for all patients with T1D.  
A             elopment 
between childhood and adulthood, specific age-based definitions vary depending on sources. 
Therefore, this paper bases adolescence on the World Health Organization (WHO) definition of 
10-19 years10. The American Diabetes Association (ADA) recognizes that the management of 
T1D in adolescents has unique considerations and should be thought of independently from other 
age groups 6. This consideration is necessary because adolescents are experiencing biological 
maturation through puberty, cognitive maturation through improvements in critical thinking and 
reasoning skills, and becoming more independent, self-aware, and more attached to peer groups6. 
This transition period is vulnerable to influences that impair the management of T1D because 
glycemic control commonly deteriorates through adolescence, and patients appear to have 
difficulties achieving glycemic control when transitioning from pediatric to adult care5,18. These 
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findings imply that psychosocial factors partially influence the ability to achieve glycemic 
control, and adolescents require additional care and support from their providers to accomplish 
their treatment goals6,11,12. 
Psychosocial factors are imperative to acknowledge and understand because of their 
impact on the management of T1D6,11,12,13,15, 17. T1D is a systemic disease requiring daily and 
intensive treatment. The constant intensity of T1D allows many elements to influence patients' 
ability to maintain glycemic control through physiological changes, comorbidities, healthcare 
access, and intersectional factors like socioeconomic status (SES), race, gender identity, and 
sexual orientation11,12,13,15,19,22,23. The relationship between glycemic control and psychosocial 
experiences is difficult to determine because it is complicated. However, increasing provider 
understanding and awareness of these impacts can lead to improved glycemic control through 
targeted interventions13,15,22,54. Moreover, it is not just the adolescent stage that impacts glycemic 
control in patients with T1D; there are many social influences on morbidity and mortality in 
patients with T1D. Across all age groups and socioeconomic strata of patients with T1D, non-
White, female patients have a mortality rate approximately three times higher than their white 
male counter parts14,16. Adolescents maintain this pattern, which makes psychosocial influences 
imperative to study to fully understand how glycemic control is affected in this age group.  
The recognition of health disparities and the influences of psychosocial factors on the 
management of T1D through an integrative team approach leads to increased glycemic control 
and decreased diabetic-related complications6,11,12,13,15, 17. This paper will explore the 
psychosocial factors that impact blood glucose control of T1D in adolescents, the interventions 
that most successfully address these elements, and recommendations to primary care providers 
on how to address these issues through multidisciplinary care.  
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Background: (Literature Review) 
Adolescent Development and Behavioral Interventions 
Adolescence is a period of biological, social, and psychological maturation. This unique 
developmental stage is vulnerable to psychosocial influences that affect the morbidity and 
mortality of adolescents with T1D diabetes. During this period of development, adolescents are 
attempting to forge autonomy financially and socially, all while battling a chronic illness that 
takes up a considerable amount of their time6. Considering the effects of psychosocial factors is 
especially important in adolescents with T1D because it is a chronic disease requiring intensive 
daily treatment. This population is navigating through quickly changing social, academic, and 
professional landscapes and are evolving physically, mentally, and socially. These changes have 
effects on the pathology of T1D forcing patients in this age group to reevaluate how to maintain 
glycemic control6. For example, puberty causes an increase in insulin resistance and hormonal 
changes that necessitates the adjustment of insulin dosages6. Refining treatments to account for 
these changes also appears to be especially challenging in this population because adjustments to 
insulin regimens have harmful side effects for adolescents6. The ADA has published protocols to 
lower HbA1c levels that are specific to adolescents. These protocols are necessary because this 
population has an increased risk for hypoglycemia due to physiologic changes unique to this age 
group6. The mixture of biologic and psychosocial changes throughout adolescence makes 
managing T1D in this population a delicate and unique process because of the impact these 
factors have on blood glucose levels. 
The most apparent change during the psychosocial development of adolescence is the 
strive to develop autonomy from their parents and to learn skills that allow them to be 
responsible for themselves. These patients are not only transitioning into adulthood physically 
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but are also maturing mentally. Although learning to manage with less supervision is an essential 
part of this stage, adolescents with T1D may need more support than has been historically 
provided. Studies show that during the years of transition to adult care from pediatric care, 
patients with T1D had an increased risk of poorer glycemic control showing HbA1c values 2.5% 
higher than their counterparts that remained in pediatric care17. This deterioration of glycemic 
control was independent of previous levels of control while in pediatric care, suggesting that it is 
some aspect of the transition that is causing poorer control in this population18. The cause of the 
barriers to transition is most likely multifactorial, including lack of standardization of transition 
protocols for providers, perceived differences in care methods from adult and pediatric providers, 
and patients feeling uncomfortable or unprepared to leave their pediatric endocrinologist18,19.  
Developing a better understanding of why adolescents seem to struggle with this 
transition is vital for improving T1D management and reducing future complications. Research 
that implements behavioral management in adolescent T1D treatments may help answer this 
question. Studies have shown that adolescents who experience higher self-efficacy and routinely 
expect positive outcomes achieve improved glycemic control20. I     
    , , and thoughts to reach set goals, known as self-
regulation, are correlated with improvements in T1D management20. These findings suggest that 
behavioral interventions may be useful in this population19,20,21,22,23.  
Research trials of behavioral management strategies studied the effects of these methods 
on glycemic control in T1D. One strategy is known as Coping Skills Training (CST). It attempts 
to improve self-management skills in stressful social situations and deter harmful coping 
mechanisms through group workshop sessions20. Adolescents taught to use CST showed 
improved glycemic control compared with individuals who did not use CST20. Although a more 
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thorough understanding of these results is still required, research does indicate that this 
population still requires emotional and physical support from caregivers to improve glycemic 
control6,18,19,20,21,22. 
Adolescence is a time that can cause shifts in family dynamics because of social and 
developmental changes. It is common for caregivers to assume that adolescent patients can take 
on managing most of their T1D on their own because this age group can independently 
accomplish many treatment tasks and have a decent understanding of the disease6. However, 
family involvement throughout adolescence appears to be important for glycemic control as 
patients with T1D appear to meet treatment goals more often when they experienced greater 
parental involvement and greater amounts of emotional and physical support6,20,22. A randomized 
control study showed improvements in glycemic control when employing behavioral 
interventions that focused on familial involvement compared to adolescents with T1D receiving 
standard care20. The two interventions studied are referred to as "Family Teamwork" and 
"Behavioral Family Systems Therapy" and resulted in improved glycemic control for two years 
and 18 months, respectively, following each intervention20. Furthermore, family conflicts 
intensify due to the added stress diabetes management has on caregivers, siblings, and 
patients6,15,22. The incorporation of behavioral interventions with T1D treatment plans that 
provided families with diabetes education, developmental education based on the age of the 
patient, and training for familial communication and conflict prevention and resolution following 
routine diabetic care appointments have been shown to improve glycemic control15,20.  
Motivational interviewing (MI) is another behavioral intervention that attempts to help 
patients decipher what intrinsically motivates their behaviors through collaborative 
conversations23. A randomized control study from 2013 found that youths with T1D provided MI 
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had a 2% decrease in HbA1c levels after three months of MI treatment25. MI implementation 
decreased HbA1c levels more in patients who had higher HbA1c levels before treatment, and all 
patients saw even greater improvements when caregivers were involved25. Behavioral 
interventions that decrease the impact psychosocial stressors have on human physiology appears 
to improve glycemic control.  
External stressors can have a substantial impact on glucose control because it is a 
complicated systemic disease. In addition to familial stress, another example of an intense 
stressor that adolescents experience is peer-related stress. The demands of SMBG, potentially 
wearing a pump and having to be more conscious of food intake, make this disease visible to 
people outside of the care team. Patients with T1D report issues with self-esteem, peer pressure, 
feeling "different," and feeling judged by their peers when caring for their diabetes25. In a 
randomized control clinical trial that aimed to determine the types of stressors adolescents 
experience, adolescents with T1D responded to interactive questions about "general life 
stressors" and "diabetes-related stressors." Researchers evaluated these responses and found that 
adolescents experienced "general life stressors related to their developmental age" most often, 
but "diabetes-related stressors" were of higher magnitude and influenced their perceptions of 
"not fitting in" with peers more than their "life stressors"25. These findings indicate that 
adolescents with T1D experience more stressors than the general population in their age group 
and that peer influences and perceptions may be a very impactful motivator to achieving 
glycemic control in adolescents.  
An increase in dependence on peer relationships and yearning for more independence is 
common in adolescence6. This combination exposes individuals to scenarios that they have not 
experienced before, such as driving and experimenting with drugs, tobacco, alcohol, and sex6. 
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Navigating through these new experiences can be difficult psychosocially and can also affect the 
management of T1D. The ADA recommends that the provider discuss these topics proactively 
with their patients with T1D6. The intensity of peer influence is also a positive factor within this 
population as peer-group interventions have shown to improve treatment adherence. 
An example of this is the shared medical appointment model (SMA). SMA is a newer 
strategy that aims to deliver patient education more effectively and enhance patient support 
through peer interactions and provider feedback26. Patients with T1D attend appointments in 
groups to ask questions and discuss issues that individuals have with provider input and 
supervision. Although there is little research on how these appointments impact glycemic control 
in adolescents with T1D, patients and providers have reported perceiving benefits such as 
increased knowledge of the disease as well as increased support during lifestyle discussions26.  
Effects of Comorbidities 
Although biopsychosocial influences impact T1D in all stages of life, adolescents appear 
to be particularly sensitive to the factors which affect their ability to properly manage diabetes by 
performing physical tasks such as SMBG and intricate cognitive tasks such as determining 
insulin dosages and how to remedy abnormal blood glucose levels. Patients with T1D experience 
comorbid conditions, including endocrine diseases, metabolic disorders, and psychological 
disorders at a much higher rate than the general population6. Studies have shown that if an 
individual is diagnosed with T1D in early adolescence, they are at increased risk for mental 
health disorders26. According to the ADA, adolescents with T1D are three times as likely to have 
a psychiatric disorder like major depressive disorder or anxiety than their peers. These patients 
also have a 30% chance of being diagnosed with a psychiatric disorder within 15-20 years of 
T1D diagnosis6,27. Psychiatric disorders are worrisome in adolescents because this age group 
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commonly struggles with glycemic control, and a decline in mental health can impair cognitive 
and physical abilities, further inhibiting the management of T1D27. 
The effects of T1D are systemic and fluctuate continuously throughout the day, allowing 
additional pathologies to influence its management severely. T1D may even contribute to the 
etiology of some disorders like psychiatric disorders27,28. Several studies have indicated a 
correlation between psychiatric disorders and T1D, although there is no consensus of the origins 
of this relationship27,28. A retrospective cohort study from 2018 shows that patients who had 
elevated levels of HbA1c (>8.5%) within the first two years of T1D diagnosis were more likely 
to be diagnosed with a subsequent psychiatric disorder such as depression or anxiety27. The same 
study concluded that 46% of 1,035 patients with T1D were diagnosed with two or more 
psychiatric disorders, and 22.8% were diagnosed with three or more psychiatric disorders, which 
are higher rates than the general population experiences27. Additionally, suicidal ideation is also 
found in much higher rates in adolescents recently diagnosed with diabetes than the general 
population, with 26.4% reporting thoughts of suicide. However, suicide attempt rates of 
adolescents with T1D reflects similar percentages of the general population6. 
Although the cause of psychiatric disorder development in T1D is unknown, research has 
found a correlation between glycemic control and mental health disorders. Poor glycemic control 
correlates with increased risk of developing a psychiatric disorder, and the ability to maintain 
glycemic control decreases when patients are diagnosed with a comorbid mental illness27. A 
retrospective cohort study in 2018 found that patients who had a preexisting mental health 
disorder when they were diagnosed with T1D were more likely to have elevated HbA1c levels 
during the first two years of management compared to patients without a preexisting psychiatric 
disorder27. Depression is also positively correlated with increased rates of DKA in adolescents6.  
 Glycemic Control in Adolescents with T1D, 13 
 
The other common mood disorder diagnosed in patients with T1D is generalized anxiety 
disorder (GAD). Anxiety poses a unique threat to T1D because its symptoms may mimic 
hypoglycemic episodes, furthering hypoglycemic anxiety, and complicating patients' ability to 
discern when they are having a hypoglycemic episode28. Anxiety surrounding the fear of needles 
is also a debilitating factor for patients newly diagnosed with diabetes and negatively affects 
glycemic control39. Implementing a multidisciplinary team specializing in T1D management has 
shown to improve glycemic control, mental health conditions, and health care costs28.  
In addition to mood disorders, eating disorders are of great concern for providers caring 
for patients with T1D because of the increased morbidity and mortality they can cause in this 
population. For example, patients with T1D who suffer from anorexia are sixteen times more 
likely to die than their non-diabetic counterparts6. Patients with T1D who are classified as 
females are twice as likely to develop an eating disorder than the general population28. However, 
the research may be biased to focus on eating disorders in females with T1D28. According to the 
ADA, 31-40% of women ages 15-30 with T1D report disordered eating patterns such as binge-
eating, and insulin restriction28. In light of this, the ADA recommends screening for eating 
disorders when patients experience recurrent DKA episodes or refractory poor glycemic 
control6. Whether there is a difference between the prevalence of eating disorders within 
adolescent diabetic populations versus the general public is still being debated. However, 
patients with diabetes are at risk for an eating disorder unique to patients with diabetes, referred 
to as "insulin omission"6. Adolescent females have higher rates of developing this disorder and 
had worsened glycemic control, microvascular complications, and hospitalizations28. Whether 
eating disorders are more prevalent in patients with diabetes than in the general population, all 
disordered eating inhibits glycemic control, increased rates of hospitalizations, and diabetic-
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related complications such as retinopathy, neuropathy, and premature death28. Because the rates 
of mood disorders, eating disorders, and psychiatric disorders in patients with diabetes are high 
in adolescents, recognizing, appropriately treating and preventing the progression of these 
conditions will improve T1D management and help prevent future diabetic-related 
complications. 
Another example of psychiatric diseases specific to T1D is Diabetic-related Distress 
(DRD). DRD is seen in 41% of patients with T1D and is defined as distress related to the self-
management of diabetes, including perceptions of support, access to quality health care, and the 
emotional toll management of chronic disease and requires different treatment strategies than 
other mental health disorders29. Distinguishing this disorder from other psychiatric disorders is 
essential because DRD is unique to patients who must adhere to diabetes management, is more 
often chronic, and is           
disorders such as depression and anxiety29. For example, based on a randomized control trial 
concluded that "emotion-focused" and "educational/behavioral" interventions in patients with 
elevated D.D. and HbA1c levels significantly improved the psychologic symptoms and increased 
glycemic control as compared to those without these treatments29. Because the improvements in 
HbA1c levels were modest compared to the decrease in D.D. symptoms, researchers suggested 
that continuous screening and implementation of behavioral management may improve HbA1c 
levels by preventing DD29. Patients with T1D have unique considerations when it comes to 
psychiatric disorders and may require multidisciplinary care to recognize, prevent, and treat these 
conditions.  
Impact of Intellectual Disabilities 
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Another population that requires special considerations and a collaborative model 
approach are individuals with intellectual disabilities (I.D.). Research suggests that populations 
that suffer from I.D. are at a heightened risk of developing T1D due to effects from 
developmental syndromes30. For example, patients who have Down Syndrome are at the highest 
risk of developing T1D compared to other intellectual disabilities30. This patient population is of 
particular concern because impairments in neurodevelopment are associated with deficiencies in 
executive functioning and may lead to worsened glycemic control outcomes because of poor 
adherence to treatments27. These patients were also more likely to have comorbidities such as 
hypertension and hyperlipidemia and worsen glycemic control than their non-disabled, T1D 
counterparts30. Obesity and a propensity for a more sedentary lifestyle have been associated with 
individuals with I.D. and are known to aggravate diabetic-related complications39. Healthcare 
access is limited among this population leading to worsened preventative healthcare, medical 
education, and treatment outcomes30.  
Compromised communication between the healthcare and the patient may be a portion of 
the problem as many people with I.D. communicate differently than the general population and 
may require extra, focused patient education strategies30. Evidence of ineffective communication 
is apparent when examining rates of routine screening tests for T1D within this population. 
People with diabetes with I.D. who were 16 years and older were likely to miss their yearly 
diabetic appointments, and even when they saw a provider, they were still less likely to receive 
the same screening evaluations as the general population30. A 2018 study in Canada showed that 
94% of patients with T1D and I.D. saw their primary care provider, but only 52% received blood 
glucose checks, 44% underwent lipid evaluation, 29% were screened for retinopathy, and only 
19% were evaluated for microalbuminuria30. Screening for diabetic-related complications and 
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additional comorbidities is a routine part of check-ups for patients with T1D and is especially 
crucial in patients with I.D. because they are at higher risk for developing comorbidities than the 
general population. 
In addition to the lack of routine screening, patients in this population have also 
demonstrated poor glycemic control in several studies. A U.K. cohort study of 125 individuals 
found that 50% of patients with I.D. and T1D did not meet HA1c goals even when they were in 
contact with their providers30. With uncontrolled glycemic levels, an individual is at risk for 
experiencing symptoms related to hyperglycemia and hypoglycemia, which can both be medical 
emergencies. Patients with I.D. are more likely to have undiagnosed medical conditions, 
including these acute complications of T1D due to a phenomenon called "diagnostic 
overshadowing"30. Providers tend to attribute the symptoms an individual is experiencing to their 
diagnosis of I.D. instead of diabetic-related complications30. This false attribution puts these 
patients at a higher risk of not receiving adequate emergent medical attention. Although studies 
have not explicitly evaluated how I.D. affects T1D management in the adolescent population, the 
studies show deteriorating glycemic control starting at age 16, which suggests that this 
population may also have difficulty transitioning from pediatric to adult care with the added 
barriers related to their I.D. diagnoses. This research also highlights the importance of screening 
in this population because poor control can be related to comorbid-related influences, and these 
patients are at risk for suffering from undiagnosed disorders. 
Intersectional Effects on Healthcare Access 
Socioeconomic Status, Healthcare Costs and Health Insurance 
The inability to access quality healthcare appears to affect specific populations 
disproportionally and leads to difficulties managing chronic conditions such as T1D 8,11,12,13,22. 
The inability to access healthcare is attributed to structural barriers within the healthcare system 
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and affects metabolic control in T1D. Patients of lower SES have worse glycemic control and 
have higher rates of complications from T1D8. Individuals on public insurance and from single-
parent households are also more likely to have poor glycemic control8,21. Adolescents of lower 
SES may experience poorer glycemic control due to a lack of resources, decreased ability for 
caregivers to provide supervision of T1D management, and an increase in social stressors than 
those of higher SES8.  
The connection between glycemic control and SES is multifactorial with physiological 
and social roots. A study by Zilioli et al. attempted to determine the cause of this phenomenon by 
examining the relationship between life stressors, diabetes-related stress, and glycemic control. 
Researches collected demographic data through questionnaires from 66 participants aged 16-20 
years and measured diurnal cortisol levels from saliva samples taken four times a day for two 
weekdays and two weekend days8. The study found that lower SES was associated with higher 
levels of stress, and researchers hypothesized that class discrimination and insufficient resources 
were responsible for this relationship8. This research team hypothesized that these psychological 
stressors might impact patients with T1D by disrupting the hypothalamic-pituitary-axis, which 
assists in regulating blood glucose levels and causes an increase in cortisol levels8. Increased 
cortisol levels result in increased gluconeogenesis, inhibition of insulin sensitivity, and decreased 
uptake of glucose in the periphery8. This study confirmed that individuals of lower SES who 
reported more stressors had patterns of cortisol release associated with higher levels of HbA1c8. 
These studies imply that patients' ability to feel secure in accessing their medical supplies and 
treatment needs impacts the care of T1D. 
Although medical needs for T1D is individualized to each patient, every patient requires 
insulin to survive. Patients with T1D also have additional provider visits, hospitalizations, and 
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more medical supplies than the average adolescent. Those services require patients with T1D to 
pay more for healthcare than the general public, but the price of insulin alone may be the most 
significant financial burden on patients with T1D31. Multiple studies show that this healthcare 
cost affects T1D management. For example, a study published in 2020 concluded that insulin 
accounted for 18% of all out-of-pocket medical spending in patients with T1D on private 
insurance31. 
Additionally, patients of lower SES were less likely to be on insulin pump therapies, and 
if patients that felt as though they were paying high costs for test strips, they were less likely to 
perform SBGM sufficiently. Both of those interventions are known to improve glycemic control 
in T1D21. Insecurities about costs can lead patients to apply unhealthy coping strategies. A 
survey from 2019 determined that 25% of individuals who visited an outpatient diabetes center 
in Connecticut reported underuse of their insulin due to cost. Of these patients, 37% of them did 
not discuss this issue with their providers32. The cost of lifesaving measures for T1D has caused 
such a burden on adolescents that there are multiple incidences of fatalities caused by patients 
purposely giving themselves lower doses or fasting to save more insulin32,33. Insecurities in 
medical payments not only affect long-term management of T1D but also can cause severe acute 
complications and appear to be an issue that patients do not eagerly bring up with their providers. 
Health insurance coverage is another uncertainty that patients with T1D in the U.S. 
experience disproportionately to the general population. The insecurity of healthcare insurance 
coverage is a massive burden because the cost of T1D is expensive due to medical supplies, the 
cost of insulin, and provider appointments. For example, the CDC estimates that adolescents 
with T1D pay an average of $9,333/year for medical costs than $1,468/y without T1D34. These 
uncertainties related to healthcare coverage can be an intense stressor for patients. A cross-
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sectional study examined data from national population-based surveys from 1999-2006 and 
found that glycemic control improved with better health insurance coverage11. A more recent 
cross-sectional study in 2018 determined through analyzing data from surveys from 2010-2016 
that although healthcare insurance coverage has improved for all ages since the Affordable Care 
Act was implemented, adolescents, as well as young adults, are still at a higher risk than other 
age groups to be uninsured35. The issue of adolescent coverage was also independently addressed 
in the ACA, allowing patients to remain on their parent's health insurance until they are 26 years 
old34. According to this research, insurance coverage is a known threat to receiving adequate 
healthcare in adolescence, impacting treatment outcomes for T1D. 
Structural Barriers  
Further social elements such as race, ethnicity, gender identity, and sexual orientation are 
related to healthcare access and healthcare outcomes12,13,17, 21,36,37. A     
  explains why cultural and ethnic minorities experience poorer health than the 
majority population36. Minority populations experience discrimination and maltreatment daily, 
which triggers the sympathetic nervous system to deal with the stress36. When experienced daily, 
this heightened physiological response is hypothesized to be a risk factor for many chronic 
diseases as it has negative systemic effects36. The majority of physicians and advanced practice 
providers identify as non-Hispanic White37,38. This homogeneity lends itself to innate cultural 
and ethnic biases that the provider carries into their practice.  This unconscious bias of the 
provider, coupled with the systemic racism that permeates the healthcare system in the U.S. 
creates a challenging environment for patients who identify out of this majority.  
As the U.S. continues to struggle with racism, a continuous influx of studies shows that 
the healthcare system is not immune to its effects. In addition to subconscious bias, race-based 
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research data, and systemic racism within the healthcare system, individuals who are Black, 
Indigenous, or People of Color (BIPOC) are more likely to face financial struggles, poorer health 
outcomes and have less access to healthcare in general21,39. Moreover, a cross-sectional analysis 
in 2013 evaluated medical data from patients with T1D between 13-20 years old and found that 
only 14% of Black patients met ADA HbA1c goals compared to 28% of Hispanic patients 34% 
of non-Hispanic White patients even when researchers controlled for SES factors17. BIPOC are 
also less likely to use diabetic technology, which can improve glycemic control. This technology 
includes continuous glucose monitors (CGM), insulin pumps, and closed-loop monitoring 
devices. Additionally, BIPOC are less likely to have intensive insulin therapies and adequate 
amounts of SMBG checks per day21,39. For example, in a 2015 cross-sectional analysis of 
patients younger than 18 years old, insulin pumps were used by 61% of non-Hispanic White 
patients, 26% of Black patients, and 39% of Hispanic patients39.  
This same study discovered that disparities are particularly striking when comparing 
glycemic control in Black and White adolescent populations. Black patients with T1D younger 
than 25 years of age were found to have increased rates of diabetic ketoacidosis leading to a 
mortality nine times higher than that of non-Hispanic White patients39. Black children of the 
highest SES had poorer glycemic control (HbA1c of 9.6%) than white children of lower SES 
(HbA1c of 8.4%)39. The fact this disparity occurs across all SES levels appears to be unique to 
Black patients with T1D because once researchers accounted for SES, there were no differences 
in glycemic control between non-Hispanic White patients and Hispanic patients39. According to 
a recent publication from the ADA, inequalities in healthcare lead to more diabetic-related 
complications in the Black population14. Black patients experience retinopathy at 46% higher 
rates than in non-Hispanic White patients14. They also suffered increased rates of nephropathy 
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that required dialysis and limb amputations14. These studies show that glycemic control is related 
to ethnicity and race, which puts racial minorities, especially Black patients, at an increased risk 
for future diabetic-related complications and worsened quality of life39,14. These studies indicate 
that Black patients have added impairments to achieving glycemic control than other racial 
minorities and White patients with T1D. 
The U.S. is comprised of a wide variety of ethnicities and cultures. Cultural perspectives 
affect how patients perceive their healthcare, adhere to their medical treatments, and receive their 
patient education. A common barrier for ethnic minorities in the U.S. healthcare system is 
language. According to the U.S. Census Bureau, 18% of the U.S. population spoke a language 
other than English, and 11.9 million households did not speak proficient English40. The U.S. 
Census Bureau expects that the number of people who speak languages other than English will 
continue rising, making it a critical psychosocial-related barrier to healthcare considerations40. 
For example, one study found that patients who did not speak English were less likely to perform 
self-monitoring blood glucose checks adequately41. Another study showed that providing a 
Spanish-speaking clinic for adolescents with T1D who spoke Spanish as their first language 
improved their glycemic control41. This finding suggests that cultural differences have important 
implications for the management of T1D and healthcare access overall.  
T1D influences most aspects of everyday life for patients. They must continuously 
monitor this disease while eating and being physically active. Nutrition appears to be an 
additional factor that creates inequality for patients with T1D because of limited access to a 
variety of nutritious foods, referred to as "food insecurity." Individuals may experience food 
insecurity because they live in an area that is physically far from stable sources of nutrition, 
known as "food deserts," or the inability to afford quality foods. Adolescents with T1D have 
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higher rates of food insecurity than the national population42. The majority of people within 
 ,     SES, and because of racial and ethnic disparities between SES classes, 
this issue disproportionately affects BIPOC and single women42. Having inadequate access to 
proper nutrition leads to unacceptable coping strategies such as skipping meals and consuming 
large portions of processed foods with a long shelf life but are low in nutritional value42. Factors 
like these may help explain the positive correlation between food insecurity rates and obesity 
rates42.  
Overall, the rate of obesity in adolescent populations has been increasing dramatically 
since the 1980s and has detrimental effects on T1D management and future complications22. 
People with T1D who also suffer from obesity are at increased risk for microvascular and 
macrovascular complications than the general population. Patients who experience food 
insecurity appear to be at especially high risk for these complications. A Canadian study from 
2014 concluded that even when researchers controlled for social, demographic and disease-
related factors, food-insecure patients with T1D were at risk for having HbA1c levels higher than 
7% and experienced more hypoglycemic episodes, emergency department visits and higher rates 
of comorbidities such as hypertension, hyperlipidemia, mood disorders, and tobacco use43. 
Employing a team-based approach that allows for a diabetic educator to provide nutritional 
education for diabetes management and a social service specialist that can help minimize food 
insecurities may improvements in HbA1c levels6. 
Cultural Influences  
Comparing glycemic control in two ethnic and cultural minorities in the U.S. exemplifies 
the effect cultural differences have on healthcare outcomes. A cross-sectional analysis of 
adolescent patients with T1D in 2016 found that 50% of patients from Latinx and Asian descent 
 Glycemic Control in Adolescents with T1D, 23 
 
did not meet their glycemic control goals22. These outcomes were due to a combination of 
English proficiency, healthcare access, SES, family dynamics, comorbidities, and acculturation 
(defined as the number of generations born in the U.S.)21,22. For example, Hispanic and Black 
populations have higher rates of obesity in youths diagnosed with T1D than other ethnicities22. 
Culture also influences how family involvement influences glycemic control. For example, a 
literature review from 2016 found that Latinx families that more recently immigrated to the U.S. 
reported higher degrees of family support and, therefore, better treatment adherence and 
improved glycemic control22. In this same study, Latinx populations with more generations born 
with the U.S. had higher rates of depression, while less acculturated Asian populations 
experienced higher rates of mental health problems22. This research implies that increasing 
attention to differences in cultures within healthcare systems and shaping diabetic education and 
care to differences in cultures may decrease diabetic-related complications for adolescents.  
In addition to race and ethnicity, gender identity, and sexual orientation of an individual 
is related to healthcare access and outcomes36. LGBTQ+ patients are more likely to avoid 
healthcare and delay seeking medical attention due to perceptions of discriminatory and unequal 
treatment from healthcare providers. This population is also twice as likely to be uninsured than 
their cisgender, heterosexual counterparts36. Adolescents in this population face considerable 
amounts of disparities while moving throughout the world, including increased risk of physical, 
emotional, and sexual abuse and increased rates of homelessness42. They also experience higher 
rates of mood disorders, substance abuse, and suicidal ideation than the general population44. 
 LGBTQ+ adolescents that suffer from T1D are not only constantly aware of their 
physical and emotional safety because of societal inequalities, but also must consistently 
maintain adequate glycemic control to function. Comparing the management of T1D in 
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LGBTQ+ populations with the general public is difficult to do as LGBTQ+ status is often 
underreported or incorrectly collected45. Additionally, information and research on T1D 
management within these populations is lacking. A cohort study conducted in Belgium in 2017 
examined the rates of T1D in transgender populations by analyzing medical records of 1,081 
transgender patients and found that T1D was 2.3 times higher within this population than the 
general population46. Defreyene et al. suggest that this relationship may be caused by the 
additional psychosocial stressors that transgender individuals experience, including stigma, 
emotional disorders, and the biopsychosocial stresses of electing to undergo gender-affirming 
hormone therapy46. Researchers need to conduct more extensive, diverse studies to decipher the 
relationship between gender identity and T1D. However, the added daily psychosocial stress that 
transgender patients experience indicates that this population requires additional support when 
managing T1D.   
Accessibility of Diabetic Specialists 
The accessibility of providers that specialize in T1D care has been shown to improve 
outcomes for patients47. Unfortunately, the number of patients diagnosed with T1D is increasing 
while the number of endocrinologists is decreasing47. According to the Endocrine Society, there 
has been a national shortage of endocrinologists that is continuing to worsen due to longer 
patient life expectancies, increasing prevalence of endocrine disorders, and insufficient numbers 
of physicians specializing in endocrine47. This trend was noticed in 2000 and has appeared to 
worsen over time47,48. In 2008 pediatric patients with T1D outnumbered endocrinologists 300:1. 
An Endocrinologist Survey in 2012 showed that this shortage continued, determining that the 
average wait for an appointment with an endocrinologist in the U.S. was 37 days47,76. Although 
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this affects all populations, it is exacerbated based on geographic location as some patients 
depending on the region they lived experienced appointment waitlists of 3-6 months48.  
Approximately 50% of pediatric endocrinologists work in academic centers within 
metropolitan areas, which indicates that in addition to being physically distant, patients in 
medically underserved areas may experience longer waitlists to get an appointment, and 
providers may have less time per patient47. A cross-sectional analysis of patient data from 2015 
showed that patients who lived within 50-miles from a pediatric endocrinologist were less likely 
to access these services than patients who lived 20 miles from specialized medical centers48. 
Furthermore, urban areas that were 50-miles away from these specialty centers had even less 
access to pediatric endocrinologists due to higher patient to physician ratios than rural areas48. 
These studies show that barriers to healthcare access include limited access to public 
transportation and longer travel times. Strategies to mitigate these barriers are essential to 
improving T1D management in adolescents because studies show that frequent communication 
with diabetes care teams improves patient outcomes with reduced acute and chronic 
complications and decreased healthcare costs6.  
Methods:  
This paper used a database search of Pubmed, National Center for Biotechnology 
Information, and Google Scholar. The keywords used during this search were "psychosocial 
effects on glycemic control of adolescents," "psychosocial effects on glycemic control," 
"glycemic control in type 1 diabetics", "psychosocial effects, glycemic control," "psychosocial, 
glycemic control," "psychologic disorders, T1D". A filter was set on these searches to include 
articles published from the years 1999-2020. Further articles were selected from the references 
used in articles found from the initial search. Articles selected focused on patients with T1D 
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between the ages of 10-19 years old, which was selected to define "adolescent" based on the 
definition from the WHO10. Articles were excluded from selection if unavailable in English 
translations.  A Registered Dietician specialist in diabetes education, Carol Brunzell RD, L.D., 
CDE, from the University of Minnesota, was interviewed via e-mail about her experience with 
adolescents with T1D within her practice.  
Discussion: 
For reasons yet to be discovered, the rising global incidence of T1D disproportionately 
impacts adolescents1,2,3. In addition to the rising number of patients with T1D, this age group has 
shown a consistent pattern of deteriorating glycemic control6,8,12,15,19,22. This combination has the 
potential to negatively impact patients with T1D, their support systems, and society as a whole 
due to increased diabetic-related complications and their resultant healthcare costs. Many studies 
identify adolescence as a vulnerable developmental period for patients with T1D. Much of the 
literature focuses on discovering which biopsychosocial factors contribute to the difficulty 
maintaining glycemic control and to what degree, but few studies attempt to discover solutions to 
these influences 5,6,11,12,15,19,22. Practitioners are encouraged to recognize that poor glycemic 
control in adolescence is likely due to an amalgamation of elements. Therefore, treatment is 
often encouraged to include a multidisciplinary approach with individualized treatment plans 
tailored to the patient's risk factors for complications, presence of comorbidities, and 
comfortability with self-management skills6. Developing advancements that help adolescents 
maintain glycemic control will decrease diabetic-related complications in future older adult 
populations, lessen healthcare costs, and increase the quality of life for millions of people 
impacted by this disease5,6,11,12,15,19,22. Increasing access to quality healthcare, prescribing 
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diabetic technology, and implementing behavioral interventions have been shown to improve 
glycemic control in adolescents5,6,11,12,15,19,22.  
Improving access to healthcare is an overarching subject that encompasses many aspects 
of control in T1D. Access to quality healthcare not only includes the ability for patients to 
physically interact with healthcare teams but also includes the ability to financial access services 
and receive necessary preventative, therapeutic, and palliative care. Psychosocial barriers can 
inhibit access to healthcare, such as screening work-ups, comprehensive patient education, a 
multidisciplinary diabetic care team, and diabetic technologies, all of which improve glycemic 
control5,6,11,12,15,19,22. Difficulty to access healthcare is influenced by psychosocial factors, 
including socioeconomic status, geographic location, race, ethnicity, gender identity, sexuality, 
and comorbidities5,6,11,12,15,19,22. Screening and evaluating for psychosocial impairments routinely 
in patients with T1D appear to be influential in preventing diabetic-related complications 
because of the powerful impact these factors can have on glycemic control6,11,13,15,17. Although 
healthcare providers should improve access to quality healthcare for their patients and decrease 
psychosocial influences on glycemic control, many systemic barriers exist above the level of 
provider control. 
Healthcare reform policies through all healthcare levels are vital to improve care for 
patients with T1D and decrease racial, economic, and cultural disparities in the management of 
the disease. For example, studies have shown that the Affordable Care Act (ACA) has begun 
decreasing inequality in healthcare by expanding coverage for populations historically 
uninsured48. The populations that most benefited from the ACA were BIPOC, youth, and those 
of lower SES. These are the same populations that are most likely to experience diabetic-related 
complications25,47. Adolescents benefited from certain aspects of this policy as individuals could 
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remain insured by their caregivers until age 26. This change in policy indicates that the transition 
from pediatric to adult care may be universally difficult for all adolescents and is not unique to 
diabetic patients further supports the theory that adolescence is a vulnerable developmental 
period requiring more healthcare support than has been historically given to this 
population6,18,19,25,49. Despite these improvements, racial, gender, socioeconomic, and cultural 
disparities in healthcare access of adolescents remain and require improvements in systemic 
changes such as Medicaid expansion49.  
A strategy that can mitigate systemic influences on glycemic control is to implement an 
integrated diabetic care team that includes team members who have in-depth knowledge of T1D 
and specialize in different aspects of its management13,20,21,23. This approach increases the quality 
of diabetic education, which can improve healthcare access by giving patients the tools to 
advocate for themselves. These tools include increased knowledge of T1D, its treatment, and 
how to navigate the healthcare system and social services. The diagnosis of T1D drastically 
alters an individual's life and is a considerable burden for adolescents already experiencing so 
many life changes. This unique developmental period requires continuous amounts of support 
and education from the diabetic care team. Integrative healthcare is especially important in 
populations that require more time and resources to provide adequate care, such as patients with 
additional comorbidities or intellectual disabilities27,28,30. For example, diabetic educators are 
essential because they increase the amount of time spent on educating patients on the minutiae of 
particular topics including diet, exercise and lifestyle choices as well as providing assistance with 
screening for comorbidities such as mental health disorders (Personal communication, Carol 
Brunzel, May 30, 2020). Increasing patient education in diabetic populations will allow them to 
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not only be able to improve their management of T1D but allow them to become better self-
advocates for their care.  
The use of a multidisciplinary, educational approach can improve healthcare disparities 
by providing focused, individualized care based on each patient's psychosocial needs. Nutrition 
and exercise are topics especially pertinent to managing T1D and requires a lot of education and 
guidance. Proper nutrition is an aspect that unites socioeconomic status, ethnicity, race, gender, 
and culture. Because food insecurity unequally impacts adolescents with T1D, females and 
ethnic minorities, improving nutritional education and providing interventions for patients to 
have access to quality nutrition could help decrease these discrepancies42. Obesity and sedentary 
lifestyles also have psychosocial-based patterns with higher rates in individuals with I.D. and 
ethnic minorities22. Regular exercise is imperative for adequate glucose control in patients with 
T1D. The same benefits of exercise seen in adult populations apply to adolescent populations, 
including decreased adipose tissue and improvements in mental and cardiovascular health6. 
Although cardiovascular fitness may not directly improve HbA1c levels, it may decrease the risk 
of other comorbidities that impair T1D management6. Despite the value of exercise in patients 
with T1D, there are still risks associated with exercise, such as fluctuations in blood glucose 
levels6. Because patients with T1D have unique considerations when it comes to exercising, it 
requires extra planning from the caregivers to ensure that complications such as hypoglycemia 
do not occur. Caregivers must also educate the patient and the authority figure involved in the 
activity to understand how to manage T1D and avoid acute complications6. Understanding how 
diet and exercise affect glycemic control in T1D is essential for obtaining adequate control of 
blood glucose levels and is improved when patients receive intensive, integrated diabetic-
education6(Personal communication, Carol Brunzel, May 30, 2020). 
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This team-based approach can also address factors unique to adolescent development that 
can negatively impact glycemic control. Adolescents are exposed to many changes through peer 
interaction and self-discovery during this developmental period that can influence glycemic 
control. The ADA recommends that providers speak with patients with T1D individually starting 
at age 12 to proactively discuss how new experiences that are common in this age group can 
affect the management of T1D as well as provide an accepting, open environment for questions 
and concerns6. Discovering one's sexuality and gender identity is an essential component of 
adolescent development38. Providers should routinely discuss safe sex practices, reproductive 
health, and provide contraceptive options6. Due to the disparities seen between LGBTQ+ 
population and cisgender heterosexual counterparts related to diabetic complications, providers 
should do what they can to reduce heteronormative and sexuality-based discrimination within 
their facilities38. Providers could encourage training on cultural sensitivity to help lessen the 
LGBTQ+ population's stressors and encourage regular communication with the diabetes care 
team38. Providers should be aware that this population may need more support in reducing 
psychosocial stressors that can worsen glycemic control, as seen in the minority stress model38. 
These aspects distinctive to adolescence require that medical management of this age group be 
considered independently from other ages, and T1D treatments should fit their specific needs. A 
team-based approach to the treatment of T1D would allow diabetic teams to more 
comprehensively screen patients for concerns related to nutrition, exercise, lifestyle, and increase 
education on these influential factors. 
Developing practices specific to improving care in adolescents is especially important 
when patients are transitioning to adult care because many patients experience deterioration of 
glycemic control during this period. Patients tend to leave pediatric care towards the very end of 
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adolescence between 18-21 years of age18. Studies have shown benefit when pediatric providers 
implement strategies to improve the transition period at least one year prior to the transfer6,18,19. 
These strategies involve a team-based approach with open communication and shared decision 
making between the adult provider, pediatric diabetes care team, family, and the patient6. In 
addition to patient education, a          
training experienced shorter transition periods, sufficient transfer of patient records, and reduced 
return of patients to pediatric care18. Despite this, providers who manage T1D report insufficient 
guidance and protocols to follow during these transfers18. Providers state that the two most 
common reasons for transferring patients are due to their continuous poor glycemic control and 
are older than 18 years old. However, neither of these reasons fit the recommended criteria for 
transferring pediatric patients according to the ADA, despite the logistics of transferring patients, 
providers reported that their primary barrier to transferring pediatric patients to adult care was 
that the patient felt an emotional attachment to the provider19. The struggle to maintain glycemic 
control during the transition to adult care and the fact these patients admit patient-provider 
relationships play an influential, emotional role during this stage further indicates how impactful 
relationships can be in adolescent populations.  
The fact that relationships influence adolescents strongly indicates that behavioral 
interventions may be a beneficial addition to T1D management because they rely on 
communication, vulnerability, and trust with the provider and group members. Behavioral 
interventions involve a provider-patient relationship and sometimes use peer-peer relationships 
to improve self-management skills, develop healthy coping methods, and help manage 
psychosocial stressors that adolescents experience20,21. Behavioral interventions such as 
motivational interviewing improve self-management skills, which are important aspects of T1D 
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treatment. Self-management of T1D requires that patients regularly perform diabetes-related care 
such as SMBG, adherence to insulin regimens, and awareness of the impacts of food intake and 
activities21,23. Researchers argue that because the success of MI is rooted in the patient's internal 
motivation, it may be particularly useful during shifts in development as in adolescence23. The 
effects of MI were improved even more when family members and caregivers were a part of the 
conversations. The importance of familial support in T1D is further supported by the fact that 
behavioral family systems therapy decreased family conflict and increased familial involvement 
in the management of T1D23. Strategies such as these may also help decrease disparities seen in 
cultural minorities such as Latinx and Asian populations because familial influences impact T1D 
management22. Although there is not enough conclusive evidence that behavioral interventions 
have a direct effect on glycemic control, they appear to be promising additions to T1D treatment 
in adolescent patients because they allow providers to target aspects specific to this 
developmental period that increase glycemic control. 
Diabetic technology is a recent addition to diabetic care that has improved the 
management of T1D in adolescents. Increasing availability, decreasing cost, and access to 
diabetic technology may improve all aspects of diabetes management, including increasing 
healthcare access, diabetes education, decreasing healthcare disparities, and overall increasing 
glycemic control16,50,52. This population is typically familiar with how the technology operates, 
and many adolescents rely on its usage for many other aspects of life, which implies that 
implementing it for T1D management may be a natural and helpful addition to these patients52.  
Recently, Web-based platforms have delivered training and guidance to managing T1D51. 
These platforms teach skills, such as coping mechanisms and problem-solving. Additionally, 
social media platforms have allowed adolescents to communicate with peers who also suffer 
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from T1D easily51. Although these platforms did not affect glycemic control, they were shown to 
improve self-management behaviors and may reduce negative psychosocial influences on T1D 
management. Less negative psychosocial influences have been correlated with fewer diabetic-
related complications in the future51. Technology has also been helpful in this population by 
developing things, including text-message services and applications that send reminders for self-
management tasks, diabetes education, and even text messages of encouragement51. Studies have 
also indicated that specific applications could support safe alcohol consumption in patients with 
T1D. Although researchers are continuing to evalute if technological interventions can improve 
glycemic control, adolescents report enjoying using these services, which indicates that this 
technology could be a beneficial addition to T1D management51.  
In addition to promoting self-management of T1D, developing technology for T1D has 
also eased burdens of daily management tasks. Devices that can provide patients with continuous 
glucose monitoring increase the amount of blood glucose checks per day and glycemic control 
improves with increased SMBG checks51. CGM usage has been shown to reduce the number of 
hypoglycemic episodes and DKA and improves HbA1c levels51. Enhancements in insulin 
delivery devices have improved quality of life and glycemic control by administering insulin 
through titratable, continuous subcutaneous infusion therapy, and meal boluses instead of 
multiple daily injections of insulin51. A subsequent advancement is the combination of these 
therapies by using sensor-augmented pumps or closed-loop systems that have also shown 
improvements in T1D management51. This technology has allowed researchers to compile large 
amounts of data that can be analyzed and evaluated to determine how to provide personalized 
treatment plans16. Studies have shown that the use of these devices improves not only glycemic 
control but also psychosocial burdens in adolescence50. The use of data analytics has been shown 
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to deliver higher-quality, individualized care to patients with T1D and may be especially helpful 
for adolescents who are experiencing changes to their treatment regimens. However, as of 2015, 
most patients between the ages of 2-25 years were not using these devices51. Although these 
technologies require additional education and are more expensive for patients than injecting 
insulin, they have been shown to improve glycemic control in T1D and could be a solution for 
populations that struggle with T1D management16,50,51. 
Additionally, racial and ethnic disparities provide barriers to accessing diabetic 
technology as Black patients are the least likely population to be prescribed and use CGM, 
insulin pumps, or closed-loop systems39. Increasing availability and accessibility to this 
technology could improve T1D management for adolescents and decrease racial disparities in 
health outcomes16,50,51. Studies have shown that racial and ethnic minorities experience worse 
diabetic complications and perform fewer SMBG checks per day than their non-Hispanic White 
counterparts46. These differences may improve with providers encouraging the usage of close-
loops systems, CGMs, and insulin-pumps50,51.  
Technology has improved self-care abilities in patients and has increased their ability to 
access diabetic care teams. Telemedicine is a growing field and is effective in delivering 
healthcare to medically underserved populations and delivering comparable quality to in-person 
visits. Adolescents, in particular, have reported high levels of satisfaction from telehealth visits 
in one study51. Meeting with a provider in a telehealth format decreases travel time and wait 
time, which leaves both providers and patients with more time51,52. Patients from rural areas also 
reported missing less school and work when using telehealth51,52. Telehealth may also help to 
close the disparities in T1D management seen between socioeconomic classes. In a randomized 
control trial in 2015, the use of telehealth appointments for T1D was evaluated in patients under 
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18 years old and concluded that telehealth appointments lessen healthcare-related costs, increase 
the number of times a patient visited and was as effective as in-person for maintaining HbA1c 
levels51. 
Telehealth has also increased the availability of diabetic specialists to areas that would 
have otherwise gone without those services. Projects like Project Extension for Community 
Health Outcomes (ECHO) train primary care providers to deliver specialized healthcare to areas 
underserved by endocrinologists through telehealth services51. In addition to telehealth, closed-
loop systems may help make up for the decreasing number of endocrinologists because analytic 
data software, as well as the ability to titrate dosages easily, allows providers to more efficiently 
tailor needs to their patients47. This improvement ultimately leaves providers with more time, 
which allows them to visit with more patients48. The programmability of closed-loop systems can 
also allow patients to send glycemic levels to providers electronically, limiting the amount of in-
person appointments patients need and increasing healthcare access to patients who have 
difficulty traveling to the office. 
Diabetic technology also has implications for reducing additional psychosocial barriers to 
adequate glycemic control by reducing the impact of comorbidities47,50. The high prevalence of 
comorbidities in this population requires providers to be aware of the screening guidelines and 
evidence-based screening tools. Providers should routinely screen adolescents with T1D for 
metabolic disorders, including hypertension and hyperlipidemia, other endocrine disorders such 
as thyroid disease and celiac disease, and mood disorders such as depression, suicidal ideation, 
anxiety and eating disorders6. Studies have shown that early identification of psychiatric 
disorders may improve diabetic treatment outcomes and improve quality of life27. Providers that 
treat patients with intellectual disabilities should be especially cautious and take care to be 
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providing all necessary screening for these patients to improve preventative medicine rates in 
this population30. Usage of technologies such as tablets has improved the efficiency of screening 
for comorbid conditions50. CMG and insulin pumps also improve care for patients who suffer 
from psychiatric disorders like anxiety and depression because they simplify care,50. These 
pumps are also programmable and have memory logs that providers can evaluate, which could 
help avoid harmful behaviors such as insulin omission50. CGM improves glycemic control in 
patients with autism who have trouble with self-management of T1D and have difficulty with 
frequent in-person visits because of adverse interactions with hospital staff47. This improvement 
in this population suggests that implementation of diabetic technology may have the ability to 
improve health outcomes for patients with intellectual disabilities and those with comorbid 
diseases but may be able to help prevent the progression of additional disorders or poor T1D 
management, thus decreasing the risk for future diabetic-related complications. Efforts are 
required to lower the cost of diabetic technology, improve insurance coverage, and encourage 
providers to prescribe it to non-Hispanic White populations. 
CONCLUSION: 
Individuals of all age groups with T1D have increased morbidity and mortality rates than 
the general population1,2,3,6. Patients diagnosed in childhood or adolescence have an even greater 
risk for diabetic-related complications because the rates increase proportionally to the length of 
time a patient has suffered from T1D1,2,3,6. Studies have shown that attaining individualized 
glycemic control goals is correlated with less risk of both acute and chronic complications of 
T1D1,2,3,6. Inadequate management of blood glucose levels can cause hypoglycemic episodes and 
DKA and eventually leads to microvascular and macrovascular complications6. In order to 
reduce diabetic-related complications in patients with T1D, providers and patients must address 
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the factors that inhibit adequate glycemic control. Many studies have shown that psychosocial 
factors can influence a      T1D   6,13,15,22,56. The 
increasing global incidence of T1D in children and adolescents, along with the decreasing 
number of endocrinologists, indicates the importance of all providers understating how to 
manage T1D, including identifying obstacles that impair patients with T1D from achieving 
glycemic control. T1D is highly prevalent in the U.S. and has deadly consequences for patients. 
The prevalence and intensity of the disease signify that facilitating the advancement towards 
sufficiently managed diabetes will decrease healthcare costs to the U.S. economy and, most 
importantly, allow millions of people to have an increased quality of life. 
Glycemic control can improve with additional future research by including 
underrepresented populations such as patients with T1D from ethnic and racial minorities, those 
with intellectual disabilities, or those who identify as LGBTQ+. In particular, these studies 
should examine how providers can improve access to healthcare through expanding 
Telemedicine and the use of newer technologies, including CGM and insulin pumps, more 
uniformly across all T1D populations to decrease diabetic-related complications. While there are 
studies that expose these disparities, relatively few provide solutions to this problem. Technology 
has the potential to improve glycemic control, so further research should also include strategies 
to make diabetic technologies more prevalent in all populations, which may rely on reducing 
costs and increasing awareness. Providers must advocate for more education regarding the 
benefits of diabetic-technologies in managing T1D in adolescents. These efforts should also 
include further advancements in the multidisciplinary approach by focusing research on how to 
utilize varying healthcare providers and specialists T1D care effectively.   
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Improving the quality of life for patients with diabetes relies heavily on improving 
glycemic control during adolescence. According to the literature reviewed in this paper, 
psychosocial factors have profound influences on the ability to attain glycemic control. The 
mitigation of these factors involves improving healthcare access through systemic reform, 
increased availability of health insurance, Telemedicine, language barriers, increasing education 
and availability of diabetic technology, and implementing behavioral interventions to improve 
self-management skills. Providers and healthcare systems must advocate for healthcare reform 
that decreases systemic disparities between groups and improves the quality of healthcare for all 
populations. Furthermore, individual behavioral interventions, familial therapies, and an 
integrative diabetic care team have improved glycemic control. Technology such as insulin-
pumps, CGMs, closed-loops systems, and analytic data software also improves healthcare access 
and quality of life in patients with T1D. Navigating through these factors to maintain glycemic 
control in adolescence requires a team effort from the diabetic team, the patient, and their 
caregivers.       
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